
|Articles|April 1, 2004
Supplements and Featured Publications
- Newsletter - Inflammation, Metabolic Syndrome, and CV Risk Reduction
- Volume 10
- Issue 1 Metab
Inflammation, Metabolic Syndrome, and CV Risk Reduction
Advertisement
Articles in this issue
almost 22 years ago
Traditional CV risk factors: Necessary, but are they sufficient?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Long-term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL
3
Value-Based Care Needs a Rebrand. Will 2026 Be the Year It Finally Gets One?
4
CheckMate 9LA at 6 Years Shows Enduring Benefits From Dual Immunotherapy Plus Chemotherapy in Metastatic NSCLC
5



























































